Relay Therapeutics
Drug Discovery · Biotechnology

Relay Therapeutics: Funding & valuation

Relay Therapeutics: 2 money records, each linked to its source.

Data updated Nov 22, 2026 · Back to the company report

Financials

Revenue of $15.4M in 2025. +53.4% on the year before. Net income −$276.5M.

$15.4MRevenue2025 · +53.4%
−$276.5MNet income2025 · +18.1%
Revenue by yearas filed, with the net income
2025$15.4Mnet income −$276.5M
2024$10Mnet income −$337.7M
2023$25.5Mnet income −$342M
2022$1.4Mnet income −$290.5M
2021$3Mnet income −$363.9M
2020$82.7Mnet income −$52.4M
Sources: SEC

Money

Relay Therapeutics: 2 money records, each linked to its source.

$410kCapital expenditureFY2025
Growth rankingsthe yearly lists of the fastest growing companies
Deloitte Technology Fast 500 2025
230% growth, 2021–2024
#324
From its filingssec.gov ↗
FY2023FY2024FY2025
Capital expenditure$4.1M$2M$410k
Stock-based compensation$86M$94.1M$62.4M
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".